rs751352361

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_006015.6(ARID1A):​c.1029_1043delAGCTGCGGCGGCGGC​(p.Ala344_Ala348del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000626 in 1,350,944 control chromosomes in the GnomAD database, including 4 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00083 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 4 hom. )

Consequence

ARID1A
NM_006015.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.51

Publications

1 publications found
Variant links:
Genes affected
ARID1A (HGNC:11110): (AT-rich interaction domain 1A) This gene encodes a member of the SWI/SNF family, whose members have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. It possesses at least two conserved domains that could be important for its function. First, it has a DNA-binding domain that can specifically bind an AT-rich DNA sequence known to be recognized by a SNF/SWI complex at the beta-globin locus. Second, the C-terminus of the protein can stimulate glucocorticoid receptor-dependent transcriptional activation. It is thought that the protein encoded by this gene confers specificity to the SNF/SWI complex and may recruit the complex to its targets through either protein-DNA or protein-protein interactions. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ARID1A Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, autosomal dominant 14
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_006015.6
BP6
Variant 1-26697417-GGCTGCGGCGGCGGCA-G is Benign according to our data. Variant chr1-26697417-GGCTGCGGCGGCGGCA-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434336.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00083 (126/151816) while in subpopulation SAS AF = 0.00208 (10/4810). AF 95% confidence interval is 0.00113. There are 0 homozygotes in GnomAd4. There are 60 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 126 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1ANM_006015.6 linkc.1029_1043delAGCTGCGGCGGCGGC p.Ala344_Ala348del disruptive_inframe_deletion Exon 1 of 20 ENST00000324856.13 NP_006006.3 O14497-1
ARID1ANM_139135.4 linkc.1029_1043delAGCTGCGGCGGCGGC p.Ala344_Ala348del disruptive_inframe_deletion Exon 1 of 20 NP_624361.1 O14497-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1AENST00000324856.13 linkc.1029_1043delAGCTGCGGCGGCGGC p.Ala344_Ala348del disruptive_inframe_deletion Exon 1 of 20 1 NM_006015.6 ENSP00000320485.7 O14497-1

Frequencies

GnomAD3 genomes
AF:
0.000831
AC:
126
AN:
151700
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000895
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00116
Gnomad EAS
AF:
0.000782
Gnomad SAS
AF:
0.00208
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000766
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00275
AC:
3
AN:
1092
AF XY:
0.00442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000600
AC:
720
AN:
1199128
Hom.:
4
AF XY:
0.000588
AC XY:
343
AN XY:
583532
show subpopulations
African (AFR)
AF:
0.000886
AC:
21
AN:
23700
American (AMR)
AF:
0.000999
AC:
9
AN:
9006
Ashkenazi Jewish (ASJ)
AF:
0.000554
AC:
9
AN:
16246
East Asian (EAS)
AF:
0.000904
AC:
25
AN:
27642
South Asian (SAS)
AF:
0.00181
AC:
85
AN:
46922
European-Finnish (FIN)
AF:
0.000250
AC:
7
AN:
27950
Middle Eastern (MID)
AF:
0.000302
AC:
1
AN:
3312
European-Non Finnish (NFE)
AF:
0.000522
AC:
519
AN:
995074
Other (OTH)
AF:
0.000893
AC:
44
AN:
49276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000830
AC:
126
AN:
151816
Hom.:
0
Cov.:
32
AF XY:
0.000809
AC XY:
60
AN XY:
74192
show subpopulations
African (AFR)
AF:
0.000892
AC:
37
AN:
41460
American (AMR)
AF:
0.00105
AC:
16
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
4
AN:
3462
East Asian (EAS)
AF:
0.000785
AC:
4
AN:
5096
South Asian (SAS)
AF:
0.00208
AC:
10
AN:
4810
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000767
AC:
52
AN:
67834
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000162
Hom.:
0
Bravo
AF:
0.000884
Asia WGS
AF:
0.00174
AC:
6
AN:
3458

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1A: BS1 -

not specified Benign:1
Mar 30, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 14, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ARID1A-related disorder Benign:1
Sep 29, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Intellectual disability, autosomal dominant 14 Benign:1
Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.5
Mutation Taster
=185/15
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751352361; hg19: chr1-27023908; COSMIC: COSV61371577; COSMIC: COSV61371577; API